Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "Biobanks Market Size, Share & Trends Analysis Report by Product, by Service (Cold Chain, Lab Processing), by Biospecimen Type, by Biobank Type (Virtual, Physical), by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
The global biobanks market size is expected to reach USD 106.9 billion by 2028 and is expected to expand at a CAGR of 6.2% from 2021 to 2028.
Biobanks continue to evolve with the introduction of new technologies such as NGS and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market.
The quality of biospecimens can significantly influence the disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples. For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples.
This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence.
Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.
Biobanks Market Report Highlights
The biobanking equipment segment accounted for the maximum revenue share in 2020 owing to the high cost of instruments coupled with an increase in the number of biorepositories.
The biobanking and repository services segment accounted for the largest revenue share of 36.0% in the market.
This is because of the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research.
Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market.
The virtual biobanks segment is anticipated to witness the fastest growth rate over the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research.
The therapeutics application segment accounted for the largest revenue share in 2020 owing to the growing popularity of cell therapies for cancer treatment.
Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment.
North America dominated the market with its wide network of centers for biosample storage in the U.S..
Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving the revenue in North America.
In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across the Asian countries.
The key players are engaged in expanding their global reach by partnering with global distributors, merger, and acquisition of other players, and entering a strategic alliance with research communities.
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Outlook
3.1 Market Dynamics
3.1.1 Market driver analysis
22.214.171.124 Continuous increase in COVID-19 cases
126.96.36.199 Increased focus on precision medicine and genetic testing
188.8.131.52 Changes in biobanking operations
184.108.40.206 Increase in the number of clinical trials globally
220.127.116.11 Growing industry and research collaborations
18.104.22.168 Technology advancement and automation
3.1.2 Market restraint analysis
22.214.171.124 Disruptions in supply chain management due to COVID-19
126.96.36.199 Challenges in sharing biobanking data & limited access to biospecimens
188.8.131.52 Sustainability challenges for biobanks
184.108.40.206 Other challenges in biobanking specimens for research
3.2 Penetration & Growth Prospect Mapping for Services, 2020
3.3 Biobanks Market - Regulatory Framework
3.3.1 Regulatory Landscape, U.S.
3.3.2 Regulatory Landscape, Canada
3.3.3 Regulatory Landscape, Europe
3.3.4 Regulatory Landscape, China
3.3.5 Regulatory Landscape, Japan
3.3.6 List of Factors/Regulations/Nature of Governments, by Country
3.4 Biobanks Market - Porter's Analysis
3.5 Biobanks Market - SWOT Analysis
Chapter 4 Biobanks Market Categorization: Products Estimates & Trend Analysis
4.1 Global Biobanks Market: Products Movement Analysis, 2020 & 2028
4.2 Biobanking Equipment
4.2.1 Global biobanking equipment market, 2017 - 2028 (USD Million)
4.2.2 Temperature control systems
220.127.116.11 Global biobanking temperature control systems market, 2017 - 2028 (USD Million)
18.104.22.168 Freezers & refrigerators
22.214.171.124 Cryogenic storage systems
126.96.36.199 Thawing equipment
4.2.3 Incubators & centrifuges
4.2.4 Alarms & monitoring systems
4.2.5 Accessories & other equipment
4.3 Biobanking Consumables
4.4 Laboratory Information Management Systems (LIMS)
Chapter 5 Biobanks Market Categorization: Services Estimates & Trend Analysis
5.1 Global Biobanks Market: Services Movement Analysis, 2020 & 2028
5.2 Biobanking & Repository
5.3 Lab Processing
5.4 Qualification/ Validation
5.5 Cold Chain Logistics
Chapter 6 Biobanks Market Categorization: Biospecimen Types Estimates & Trend Analysis
6.1 Global Biobanks Market: Biospecimen Types Movement Analysis, 2020 & 2028
6.2 Human Tissues
6.3 Human Organs
6.4 Stem Cells
6.4.1 Global stem cell biobanking market, 2017 - 2028 (USD Million)
6.4.2 Adult stem cells
6.4.3 Embryonic stem cells
6.4.4 Induced Pluripotent Stem (IPS) Cells
6.4.5 Other Stem Cells
6.5 Other Biospecimens
Chapter 7 Biobanks Market Categorization: Biobank Types Estimates & Trend Analysis
7.1 Global Biobanks Market: Biobank Types Movement Analysis, 2020 & 2028
7.2 Physical/Real Biobanks
7.2.1 Global physical/real biobanks market, 2017 - 2028 (USD Million)
7.2.2 Tissue biobanks
7.2.3 Population based biobanks
7.2.4 Genetic (DNA/RNA) based biobanks
7.2.5 Disease based biobanks
7.2.6 Global disease based biobanks market, 2017 - 2028 (USD Million)
7.3 Virtual Biobanks
Chapter 8 Biobanks Market Categorization: Application Estimates & Trend Analysis
8.1 Global Biobanks Market: Application Movement Analysis, 2020 & 2028
8.3 Drug Discovery & Clinical Research
8.4 Clinical Diagnostics
Chapter 9 Biobanks Market Categorization: Regional Estimates & Trend Analysis, by Products, Services, Biospecimen Types, Biobank Types, & Applications
9.1 Biobanks Market Share by Region, 2020 & 2028
Chapter 10 Competitive Landscape
Thermo Fisher Scientific, Inc.
VWR International, LLC.
Tecan Trading AG.
Becton, Dickinson and Company (BD)
Charles River Laboratories
STEMCELL Technologies Inc.
Virgin Health Bank
For more information about this report visit https://www.researchandmarkets.com/r/m94vrg
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900